Abstract: A drill bit for drilling a cavity or a recess into a skull, wherein the cavity or the recess is configured to receive an implantable fixture screw unit of a hearing aid system, is disclosed. The drill bit includes a first part including a drill tip with a first drill diameter, wherein the drill tip comprises a tip angle of between 137 degrees to 143 degrees along a longitudinal axis of the drill bit and wherein the drill tip comprises a back rake angle of between ?1 degree and +1 degree, in particular a back rake angle of substantially 0 degrees, a second part including a plurality of flute blades with a second drill diameter, wherein the second drill diameter is greater that the first drill diameter, and a transition part which is arranged between the first part and the second part and along the longitudinal axis, wherein the transition part includes a body clearance.

Abstract: The present embodiments refer to a controlling system configured to be installed in a recreational vehicle, cooling devices comprising or coupled to such controlling systems, a recreational vehicle comprising such controlling systems and methods for controlling cooling the cooling devices. The controlling system comprises a central processing unit, a read out unit and a controlling unit and is configured to be coupled to a plurality of electronic devices of the recreational vehicle. The read out unit of the controlling system is configured to read out data from the electronic devices and/or sensors of the recreational vehicle coupled to the controlling system and to forward the read out data to the central processing unit. The central processing unit is configured to receive and to process the read out data received from the read out unit and to forward processed data to the controlling unit.

Abstract: An apparatus for producing a cementitious board includes a conveying device for conveying a first liner with first overlap sections-in a transport direction, at least one slurry feeder device for applying at least one layer of at least one slurry comprising a cementitious material onto the first liner, a liner feeding device for providing and arranging a second liner with second overlap sections such that it contacts the first overlap sections of the first liner wherein the at least one layer of the at least one slurry is arranged between the first liner and the second liner, an adhesive foam feeder for providing an adhesive foam on at least one of the first or the second overlap sections, and a means for bonding the first liner and the second liner.

Abstract: Method for producing a cementitious board (1), wherein a first liner (2) with first overlap sections (5) is provided and furnished with at least one layer of at least one slurry comprising a cementitious material (3); a second liner (4) with second overlap sections (8) is provided and arranged such that it contacts the first overlap sections (5) of the first liner (2), wherein the at least one layer of the at least one slurry (3) is arranged between the first liner (2) and the second liner (4); an adhesive foam (6) is provided at least partly on at least one of the first or second overlap sections (5, 8); and the first liner (2) and the second liner (4) are bonded via the adhesive foam (6) in the overlap sections (5, 8).

Abstract: The present invention is concerned with plasterboards including at least two layers A and B of different composition, wherein layer A includes a calcium sulfate binder and a synthetic polymer foam and the layer B includes a calcium sulfate binder and a surfactant foam and wherein the at least one layer A is a surface layer. Improved nail pull resistance can be achieved in lightweight plasterboards, if foamed synthetic polymer is present in a surface layer. The present invention further concerns a method for the production of corresponding products, an apparatus for the production of such products as well as the use of synthetic polymer foam in a surface layer to produce plasterboards with high nail pull resistance at a minimal amount of synthetic polymer.

Abstract: Method for producing a cementitious board (1), wherein a first liner (2) with first overlap sections (5) is provided and furnished with at least one layer of at least one slurry comprising a cementitious material (3); a second liner (4) with second overlap sections (8) is provided and arranged such that it contacts the first overlap sections (5) of the first liner (2), wherein the at least one layer of the at least one slurry (3) is arranged between the first liner (2) and the second liner (4); an adhesive foam (6) is provided at least partly on at least one of the first or second overlap sections (5, 8); and the first liner (2) and the second liner (4) are bonded via the adhesive foam (6) in the overlap sections (5, 8).

Abstract: The invention concerns a method for producing gypsum boards, wherein a liquefier for the gypsum slurry is foamed with gas to provide a foam having a water content of less than 85 wt.-%, then incorporated into a gypsum/water mixture and the mixture thus obtained is applied on a two dimensional substrate. The incorporation of the liquefier in foamed form allows for a significant reduction of the amount of liquefier required to provide a desired flowability of the gypsum/water mixture, thus allowing the production of gypsum boards with similar characteristics with less liquefier. The invention further concerns gypsum board prepared using this process, apparatuses for producing gypsum boards using this process and the use of a corresponding liquefier foam to minimize the amount of liquefier required to establish a desired flowability of a gypsum/water mixture.

Abstract: The present invention relates to emulsion-templated silica micro and nano-capsules- and methods for making them. In particular, the template emulsion is stabilized by a biosurfactant that also assists in nucleating the silica shell Mineralizing biosurfactants and stabilized micro- and nano-emulsions useful in forming the emulsion-templated micro- and nano-capsules, and methods for the use of the silica micro- and nano-capsules are also described.

Abstract: An UHMWPE film having a tensile strength of at least 2.0 GPa, a tensile energy to break of at least 30 J/g, an Mw of at least 500 000 gram/mole, and a Mw/Mn ratio of at most 6, and a film width of at least 5 mm. The film may be manufactured via a process which comprises subjecting a starting UHMWPE with a weight average molecular weight of at least 500 000 gram/mole, an elastic shear modulus determined directly after melting at 160° C. of at most 1.4 MPa, and a Mw/Mn ratio of at most 6 to a compacting step and a stretching step under such conditions that at no point during the processing of the polymer its temperature is raised to a value above its melting point. The film may be used as starting material in any applications where high tensile strength and high energy to break are important. Suitable applications include ballistic applications, ropes, cables, nets, fabrics, and protective applications.

Abstract: The present invention provides compositions relating to viral capsomeres which comprise foreign immunogenic sequences for use in pharmaceutical compositions and methods of producing such compositions, and related isolated or purified protein and nucleic acid molecules, vectors, host cells, compositions, and methods of use to augment an immune response, immunize an animal and prophylactically or therapeutically treat a disease, disorder or condition. The viral capsomere may be derived from a polyomavirus and comprise an immunogen of interest at the N-terminus and further at the C-terminus and/or at one or more exposed loops of the capsomere.

Abstract: The invention relates to nanoemulsions useful for analytical techniques and delivery of cargoes such as pharmaceutically active agents. In particular, the invention relates to nanoemulsions comprising an oil phase dispersed in an aqueous phase and at least two peptide surfactants adsorbed at the liquid-liquid interface, one peptide surfactant comprising a short peptide sequence having ?-helical propensity and at least one second polypeptide surfactant comprising at least two peptide sequences having ?-helical propensity linked by a linking sequence of 3 to 11 amino acid residues. Optionally the at least one second polypeptide surfactant comprises at least one pharmacokinetic modifying agent and/or a targeting agent. Furthermore, the nanoemulsion may further comprise a cargo such as a pharmaceutically active agent.

Abstract: The present invention pertains to a UHMWPE film having a tensile strength of at least 2.0 GPa, a tensile energy to break of at least 30 J/g, an Mw of at least 500 000 gram/mole, and a Mw/Mn ratio of at most 6. The film may be manufactured via a process which comprises subjecting a starting UHMWPE with a weight average molecular weight of at least 500 000 gram/mole, an elastic shear modulus determined directly after melting at 160° C. of at most 0.9 MPa, and a Mw/Mn ratio of at most 6 to a compacting step and a stretching step under such conditions that at no point during the processing of the polymer its temperature is raised to a value above its melting point. The film may be used as starting material in any applications where high tensile strength and high energy to break are important. Suitable applications include ballistic applications, ropes, cables, nets, fabrics, and protective applications.

Abstract: The present invention relates to emulsion-templated silica micro and nano-capsules- and methods for making them. In particular, the template emulsion is stabilized by a biosurfactant that also assists in nucleating the silica shell Mineralizing biosurfactants and stabilized micro- and nano-emulsions useful in forming the emulsion-templated micro- and nano-capsules, and methods for the use of the silica micro- and nano-capsules are also described.

Abstract: The invention relates to nanoemulsions useful for analytical techniques and delivery of cargoes such as pharmaceutically active agents. In particular, the invention relates to nanoemulsions comprising an oil phase dispersed in an aqueous phase and at least two peptide surfactants adsorbed at the liquid-liquid interface, one peptide surfactant comprising a short peptide sequence having ?-helical propensity and at least one second polypeptide surfactant comprising at least two peptide sequences having ?-helical propensity linked by a linking sequence of 3 to 11 amino acid residues. Optionally the at least one second polypeptide surfactant comprises at least one pharmacokinetic modifying agent and/or a targeting agent. Furthermore, the nanoemulsion may further comprise a cargo such as a pharmaceutically active agent.

Abstract: The present invention relates to designed polypeptide biosurfactants that may be prepared by recombinant technology in commercially useful amounts and purified by simple non-chromatographic methods. The designed polypeptide biosurfactants comprise at least one stimuli-responsive amino acid residue or at least one glutamine or asparagine residue and may be useful in modulating the stability of a foam, alone or in combination with an ?-helical peptide. The designed polypeptide biosurfactant may be useful in the formation and collapse of foams in foods, beverages, pharmaceuticals, personal care products, cosmetics, cleaning products, mineral recovery, bioremediation, oil recovery and laundry products. The designed biosurfactants may also be useful in recombinant production and purification of peptides, polypeptides and proteins.

Abstract: The present invention provides compositions relating to viral capsomeres which comprise foreign immunogenic sequences for use in pharmaceutical compositions and methods of producing such compositions, and related isolated or purified protein and nucleic acid molecules, vectors, host cells, compositions, and methods of use to augment an immune response, immunise an animal and prophylactically or therapeutically treat a disease, disorder or condition. The viral capsomere may be derived from a polyomavirus and comprise an immunogen of interest at the N-terminus and further at the C-terminus and/or at one or more exposed loops of the capsomere.

Abstract: A ballistic-resistant moulded article containing a compressed stack of sheets that contain high molecular weight polyethylene tapes. The direction of the polyethylene tapes within the compressed stack is not unidirectional. At least part of the tapes have a width of at least 2 mm, a thickness to width ratio of at least 10:1, and a density of at most 99% of the theoretical tape density. The moulded article is made of tapes that have a density below the theoretical density of the tapes.

Abstract: A process for manufacturing high molecular weight polyethylene fibers, including subjecting a polyethylene tape with a weight average molecular weight of at least 500,000 grams/mole, a Mw/Mn ratio of at most 6, and a 200/110 uniplanar orientation parameter of at least 3 to a force in the direction of the thickness of the tape over the entire width of the tape. A polyethylene fiber having a Mw of at least 500 000 gram/mole, a Mw/Mn ratio of at most 6, and a 020 uniplanar orientation value of at most 55°.

Abstract: The present invention pertains to a polyethylene film and a process for manufacturing such film. The polyethylene film may have a ratio between the strength in a first direction in the film plane and the strength in a second direction in the film plane perpendicular to the first direction in the range of 0.1-10:1, the strength in at least one direction being at least 0.2 Gpa. The process for manufacturing a polyethylene film may have a starting UHMWPE polymer with an average molecular weight of at least 500,000 grams/mole, an elastic shear modulus determined directly after melting at 160° C. of at most 1.4 MPa, and a Mw/Mn ratio of at most 6 to a solvent-free compacting process and a stretching process under such conditions that at no point during the process the temperature of the intermediate polymer film is raised to a value above its melting point.

Abstract: An isolated protein comprising a VP1 amino acid sequence wherein one or more exposed loops within said VP1 has an insertion of an amino acid sequence from a virus protein other than VP1, and encoding nucleic acid, are provided. Typically, the virus protein other than VP1 is derived from an influenza virus and in particular, avian influenza virus. The isolated protein may have an insertion of amino acid sequence from a single protein or a plurality of proteins. Also provided are expression constructs, VLPs, pharmaceutical compositions, vaccines and methods of treatment that may be useful in the prophylactic and/or therapeutic treatment of any disease of viral origin, and in particular, influenza virus.